AstraZeneca

AstraZeneca (AZN) Stock Price, Fundamentals & Analysis

StockNasdaq StockholmOMXS30Healthcare

Price

1,640.5 SEK

+0.64%

Last trade: Sep 25, 2026, 05:29 PM GMT+2

Updated: Sep 27, 2026, 11:41 AM GMT+2

Price history

Over the past year AZN traded between 1,392 SEK and 1,903 SEK, closing at 1,640.5 SEK on Sep 25, 2026.

Key statistics

Market cap2.54T SEK
P/E ratio (TTM)25
Forward P/E16.2
EPS (TTM)65.74 USD
Dividend yield1.84%
Annual dividend30.24 SEK
Ex-dividend dateAug 6, 2026
Payout ratio47%
52-week range1,385 – 1,925.5
52-week change16.1%
Beta0.21
Price / book50.59
Revenue (TTM)61.37B USD
Revenue growth (YoY)6.4%
Gross margin81.7%
Operating margin23.5%
Profit margin17%
Return on equity22%
Debt / equity64.2
Volume376,019
Average volume570,355
Next earningsOct 30, 2026
ExchangeStockholm

Profile

Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
96,100
Headquarters
Cambridge, United Kingdom

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and Symbicort pMDI. It also provides Beyfortus, Kavigale, Evusheld, Fluenz/FluMist, Synagis, Kanuma, Ultomiris, Koselugo, Voydeya, Soliris, Strensiq, Nexium, and other medicines.

Overview

What AZN does

AstraZeneca PLC (symbol AZN) is a biopharmaceutical company headquartered in Cambridge, United Kingdom. It discovers, develops, manufactures, and commercializes prescription medicines across a broad portfolio that includes treatments in oncology, cardiovascular, respiratory, and rare diseases. The stock trades on the Nasdaq Stockholm under the ticker AZN and is part of the Nasdaq Stockholm stocks universe.

Key numbers explained

  • The current price is 1,640.5 SEK, with a +0.64% move today.
  • The trailing P/E ratio of 25 shows how much investors pay per unit of recent earnings; a lower figure can suggest a cheaper valuation relative to current earnings.
  • The forward P/E ratio of 16.2 uses expected future earnings, which can be more relevant for growth stocks.
  • The dividend yield of 1.84% tells you the annual dividend as a percentage of the share price; the exDividendDate is Aug 6, 2026.
  • Beta of 0.21 indicates the stock has historically moved less than the broader market, a sign of lower volatility.
  • The price-to-book ratio of 50.59 compares the market price to the company's book value per share; a high number often reflects strong intangible assets or market expectations.
  • Return on equity of 22% measures how effectively the company generates profit from shareholders' equity.
  • The debt-to-equity ratio of 64.2% shows the proportion of debt used to finance the business relative to equity.

What to watch

  • The price change over the last 52 weeks of 16.1% and the 52-week range of 1,385 – 1,925.5 show where the current price sits within the recent trading band.
  • Revenue growth of 6.4% year over year and a profitMargin of 17% give a sense of top-line expansion and cost control.
  • The nextEarningsDate of Oct 30, 2026 is a key calendar event for any stock.
  • AstraZeneca competes with peers such as Sun Pharma (SUNPHARMA), Zhangzhou Pientzehuang Pharmaceutical (600436), Philips (PHIA), IHH Healthcare Berhad (5225), Siemens Healthineers (SHL), Sonic Healthcare (SHL), and Chong Kun Dang (185750), all of which operate in healthcare or related sectors.

Latest news & filings

No recent headlines.

Frequently asked questions

Does AZN pay a dividend?

Yes. AstraZeneca pays a dividend with a yield of 1.84%, and the next ex-dividend date is Aug 6, 2026.

What is the AZN P/E ratio?

The trailing P/E ratio is 25, while the forward P/E ratio based on expected earnings is 16.2.

Where can I buy AZN?

AstraZeneca trades on the Nasdaq Stockholm under the symbol AZN.

How big is AstraZeneca?

It has a market cap of 2.54T SEK, 96,100 employees, and trailing 12-month revenue of 61.37B USD.

How volatile is AZN?

Its beta of 0.21 suggests it has historically been less volatile than the broader market.

When is the next earnings report?

The next earnings date is Oct 30, 2026.

Track AZN in your portfolio

Hold AZN at XTB, IBKR, Tradeville, Revolut or Trading 212? InvestPane brings every broker into one dashboard — allocation, performance and dividends in one place.

Start free

Data updated Sep 27, 2026, 11:41 AM GMT+2. Sources: Yahoo Finance, Bucharest Stock Exchange.

For information and education only — not investment advice. Prices may be delayed. The overview is generated with AI from the data shown on this page.